BusinessfromIrish Independent1 week agoPfizer makes $4.9bn bet on obesity drugsPfizer will acquire obesity startup Metsera for about $4.9bn, paying $47.50 per share plus up to $22.50 in milestone-based payments.
Alternative medicinefromtime.com4 months agoWhich Weight-Loss Drug Works the Best?Zepbound shows superior weight loss compared to Wegovy in a recent clinical trial, influencing treatment decisions for obesity management.